Cargando…

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439988/ https://www.ncbi.nlm.nih.gov/pubmed/34517384 http://dx.doi.org/10.1097/CM9.0000000000001765

Ejemplares similares

Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
por: Wei, Hong-Chun, et al.
Publicado: (2021)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Effects of Creative Expression Therapy for Older Adults with Mild Cognitive Impairment at Risk of Alzheimer’s Disease: A Randomized Controlled Clinical Trial [Corrigendum]
Publicado: (2023)

Methylation of the RIN3 Promoter is Associated with Transient Ischemic Stroke/Mild Ischemic Stroke with Early Cognitive Impairment [Corrigendum]
Publicado: (2021)

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
por: Rosenberg, Anna, et al.
Publicado: (2019)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
Publicado: (2015)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Cerebral Amyloid Positivity Prediction Models Using Clinical Data in Subjects With Mild Cognitive Impairment and Dementia
por: Joo, Soo Hyun, et al.
Publicado: (2021)

Detection of cognitive impairment using a machine-learning algorithm [Corrigendum]
Publicado: (2019)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigenda: The Prevalence of Dementia and Cognitive Impairment in our Acute Medical Admissions
por: Cowley, Sharon, et al.
Publicado: (2018)

Characteristics Predicting a High Caregiver Burden in Patients with Vascular Cognitive Impairment: Using the Apriori Algorithm to Delineate the Caring Scenario [Corrigendum]
Publicado: (2021)

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Corrigendum: Early active immunization with Aβ(3–10)-KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice
Publicado: (2020)

Corrigendum: Association of Source of Memory Complaints and Increased Risk of Cognitive Impairment and Cognitive Decline: A Community-Based Study
Publicado: (2018)

Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment
por: Yoon, Hyung-Jun, et al.
Publicado: (2019)

Corrigendum: Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
Publicado: (2021)

Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
por: Sörensen, Arnd, et al.
Publicado: (2020)

Corrigendum to “Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI”
por: Ito, Keiichi, et al.
Publicado: (2017)

The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes
por: Michaud, Tzeyu L., et al.
Publicado: (2017)

CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG [Corrigendum]
Publicado: (2023)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Publicado: (2017)

Neutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia
por: Cho, KyoungJoo
Publicado: (2023)

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
por: Butt, Zeeshan, et al.
Publicado: (2018)

Corrigendum to “Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience”
por: Senanarong, Vorapun, et al.
Publicado: (2017)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma [Corrigendum]
Publicado: (2022)

Corrigendum to “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients”
por: Bi, Wei-Kang, et al.
Publicado: (2021)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

The Blood Biomarkers of Thyroid Cancer [Corrigendum]
Publicado: (2022)

Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level [Corrigendum]
Publicado: (2020)

Corrigendum to “The Clinical and Radiological Characteristics of Inflammatory Myofibroblastic Tumor Occurring at Unusual Sites
por: Zeng, Xuewei, et al.
Publicado: (2020)

Role of cognitive reserve in progression from mild cognitive impairment to dementia
por: Allegri, Ricardo F., et al.
Publicado: (2010)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6j2s6sljm8fm10lftcqkeg3sm8